Dimerix

Dimerix OCF Margin

The Operating Cash Flow Margin of Dimerix (DXB.AX) as of Oct 11, 2026 is -1,190.94 %. In the previous year, Operating Cash Flow Margin was 3,112.75 % — a change of -138.26% (lower).

OCF Margin

-1,190.94 %

YoY

-138.26%

Last updated:

Operating Cash Flow Margin of Dimerix is 2026 -1,190.94 % . Operating Cash Flow Margin of Dimerix was 2025 3,112.75 % . It decreases by -138.26% lower compared to the previous year.

The Dimerix OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2019
-190.10 AUD
Jan 1, 2020
-201.69 AUD
Jan 1, 2021
-145.56 AUD
Jan 1, 2022
-207.89 AUD
Jan 1, 2023
-34,605.99 AUD
Jan 1, 2024
-1,200.39 AUD
Jan 1, 2025
3,112.75 AUD
Jan 1, 2026
-1,190.94 AUD
The Dimerix OCF Margin history
YEAROCF MarginYoY
-1,190.94 %-138.26%
3,112.75 %-359.31%
-1,200.39 %-96.53%
-34,605.99 %+16,546.29%
-207.89 %+42.82%
-145.56 %-27.83%
-201.69 %+6.09%
-190.10 %-50.18%
-381.58 %+13.51%
-336.16 %+48.75%
-225.99 %-3.69%
-234.63 %+47.12%
-159.49 %—
Access this data via the Eulerpool API

Dimerix Stock analysis

What does Dimerix do? Dimerix Ltd is an Australian biotechnology company specializing in the development of innovative therapies for various medical needs. Their business model is based on identifying new targets for drug development, often through collaborations with other biotech or pharmaceutical companies. Dimerix focuses on cancer therapy, utilizing their innovative platform technology to identify and test a variety of drug candidates. They also have a pipeline of medications for kidney and lung diseases, as well as inflammation and pain. Dimerix actively seeks partnerships with other companies and research institutions to bring innovative therapies to market. One of their key products, DMX-200, is currently in phase II clinical trials for the treatment of kidney diseases and has shown promising results. Overall, Dimerix is well-positioned to continue bringing successful therapies to market in the future. Dimerix is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Dimerix stock

Operating Cash Flow Margin of Dimerix is -1,190.94 % in 2026.

Operating Cash Flow Margin of Dimerix changed from 3,112.75 % to -1,190.94 %, representing a -138.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Dimerix since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Dimerix with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Dimerix

All Key Metrics — Dimerix